Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Carbocysteine-L-lysine Powder vs Syrup
NCT02858193Phase 1Completed
- Sponsor
- Dompé
- Start
- Jul 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of carbocisteine lysine salt in bronchitis (2 arms), sponsored by Dompé. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve from time 0 to last measurable concentration. Started Jul 2016; status: completed.
02
Drugs
carbocisteine lysine salt
03
Conditions
bronchitis
Beyond the preview
Go deeper on NCT02858193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858193.